MI180021 / PharmaMar - LARVOL DELTA

PharmaMar presents at MaNaPro & ECMNP its latest advances in the development of compounds of marine origin (Pharmamar Press Release) - "PharmaMar (MSE:PHM) presents its latest advances in the development of its marine-derived compounds with antitumor activity at the XVI International Symposium on Marine Natural Products (MaNaPro) and the XI European Conference on Marine Natural Products (ECMNP)...PharmaMar will present two posters with two new ADCs: MI180021 and MI130110....Finally, a poster on its latest compound in clinical development, PM14, will also be presented. This poster shows the chemical synthesis and activity of the compound in breast, sarcoma and gastric tumors in pre-clinical studies."

Preclinical